Show simple item record

dc.contributor.authorWolff, A.
dc.contributor.authorLazar, A.
dc.contributor.authorBondarenko, I.
dc.contributor.authorGarin, A.
dc.contributor.authorBrincat, S.
dc.contributor.authorChow, L.
dc.contributor.authorSun, Y.
dc.contributor.authorNeskovic-Konstanovic, Z.
dc.contributor.authorGuimaraes, R.
dc.contributor.authorFumoleau, P.
dc.contributor.authorChan, Arlene
dc.contributor.authorHachemi, S.
dc.contributor.authorStrahs, A.
dc.contributor.authorCincotta, M.
dc.contributor.authorBerkenblit, A.
dc.contributor.authorKrygowski, M.
dc.contributor.authorKang, L.L.
dc.contributor.authorMoore, L.
dc.contributor.authorHayes, D.
dc.date.accessioned2017-01-30T11:12:18Z
dc.date.available2017-01-30T11:12:18Z
dc.date.created2014-11-19T01:13:19Z
dc.date.issued2013
dc.identifier.citationWolff, A. and Lazar, A. and Bondarenko, I. and Garin, A. and Brincat, S. and Chow, L. and Sun, Y. et al. 2013. Randomized phase III placebo-controlled trial of letrozole plus oral temsirolimus as first-line endocrine therapy in postmenopausal women with locally advanced or metastatic breast cancer. Journal of Clinical Oncology. 31 (2): pp. 195-202.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/9375
dc.publisherAmerican Society of Clinical Oncology
dc.titleRandomized phase III placebo-controlled trial of letrozole plus oral temsirolimus as first-line endocrine therapy in postmenopausal women with locally advanced or metastatic breast cancer
dc.typeJournal Article
dcterms.source.volume31
dcterms.source.number2
dcterms.source.startPage195
dcterms.source.endPage202
dcterms.source.issn0732 183X
dcterms.source.titleJournal of Clinical Oncology
curtin.accessStatusFulltext not available


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record